Trust Point Inc. Cuts Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Trust Point Inc. lowered its holdings in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 46.2% in the 4th quarter, Holdings Channel reports. The firm owned 4,715 shares of the company’s stock after selling 4,044 shares during the period. Trust Point Inc.’s holdings in Addus HomeCare were worth $591,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of ADUS. Connor Clark & Lunn Investment Management Ltd. bought a new position in Addus HomeCare during the 3rd quarter valued at about $1,622,000. JPMorgan Chase & Co. raised its holdings in shares of Addus HomeCare by 10.2% during the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock valued at $24,371,000 after purchasing an additional 16,997 shares during the last quarter. Harbor Capital Advisors Inc. raised its holdings in shares of Addus HomeCare by 127.7% during the third quarter. Harbor Capital Advisors Inc. now owns 64,311 shares of the company’s stock valued at $8,555,000 after purchasing an additional 36,071 shares during the last quarter. Principal Financial Group Inc. lifted its position in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after purchasing an additional 75,409 shares during the period. Finally, Quest Partners LLC grew its position in Addus HomeCare by 4,087.0% in the 3rd quarter. Quest Partners LLC now owns 11,263 shares of the company’s stock worth $1,498,000 after purchasing an additional 10,994 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $123.02 on Wednesday. The company has a market capitalization of $2.23 billion, a P/E ratio of 28.15, a P/E/G ratio of 1.62 and a beta of 1.00. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.72. The firm’s 50 day simple moving average is $126.87 and its two-hundred day simple moving average is $127.42.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 EPS. On average, sell-side analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ADUS shares. KeyCorp started coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Stephens boosted their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, nine have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Buy” and a consensus price target of $134.22.

Check Out Our Latest Analysis on Addus HomeCare

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,750 shares of company stock valued at $4,930,750 over the last 90 days. Company insiders own 4.60% of the company’s stock.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.